Intermittent androgen suppression in the treatment of prostate cancer: An update of the vancouver experience.

被引：0
|
作者：
Zappavigna, C. [1 ]
Studd, R. C. [1 ]
Hurtado-Coll, A. [1 ]
Goldenberg, S. L. [1 ]
机构：
[1] Univ British Columbia, Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC V5Z 1M9, Canada
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2007年 / 55卷 / 01期
关键词：
D O I：
10.1097/00042871-200701010-00174
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [41] Intermittent androgen suppression: Rationale and clinical experience
    Gleave, M
    Bruchovsky, N
    Goldenberg, SL
    Rennie, P
    RECENT ADVANCES IN PROSTATE CANCER AND BPH, 1997, : 109 - 120
  • [42] Intermittent androgen deprivation for clinically localized prostate cancer: Initial experience
    Grossfeld, GD
    Small, EJ
    Carroll, PR
    UROLOGY, 1998, 51 (01) : 137 - 144
  • [43] Intermittent Versus Continuous Androgen Deprivation Treatment of Prostate Cancer
    Zhu, Jianhong
    Zheng, Yayuan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31) : 4024 - 4024
  • [44] Nonlinear system identification for prostate cancer and optimality of intermittent androgen suppression therapy
    Suzuki, Taiji
    Aihara, Kazuyuki
    MATHEMATICAL BIOSCIENCES, 2013, 245 (01) : 40 - 48
  • [45] Model predictive control for optimally scheduling intermittent androgen suppression of prostate cancer
    Hirata, Yoshito
    Azuma, Shun-ichi
    Aihara, Kazuyuki
    METHODS, 2014, 67 (03) : 278 - 281
  • [46] Intermittent androgen suppression for prostate cancer: Canadian Prospective Trial and related observations
    Bruchovsky, N
    Klotz, LH
    Sadar, M
    Crook, JM
    Hoffart, D
    Godwin, L
    Warkentin, M
    Gleave, ME
    Goldenberg, SL
    MOLECULAR UROLOGY, 2000, 4 (03) : 191 - 199
  • [47] Intermittent androgen suppression in the management of prostate cancer: A phase II comparative study
    Irani J.
    Prostate Cancer and Prostatic Diseases, 2000, 3 (Suppl 1) : S20 - S20
  • [48] Intermittent androgen castration: A biological reality during intermittent treatment in metastatic prostate cancer?
    Mottet, N
    Lucas, C
    Sene, E
    Avances, C
    Maubach, L
    Wolff, JM
    UROLOGIA INTERNATIONALIS, 2005, 75 (03) : 204 - 208
  • [49] Duration of Androgen Suppression in the Treatment of Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2009, 182 (05): : 2312 - 2313
  • [50] Phase II study of intermittent androgen suppression (IAS) in prostate cancer patients.
    Bracarda, S
    Rosi, P
    De Angelis, V
    Mearini, E
    Porena, M
    Tonato, M
    ANNALS OF ONCOLOGY, 2000, 11 : 31 - 31
12345